LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16

Search options

  1. Article: Hypovitaminosis D Influences the Clinical Presentation of Immune Thrombocytopenia in Children with Newly Diagnosed Disease.

    Petrovic, Davor / Benzon, Benjamin / Batinic, Marijan / Culic, Srđana / Roganovic, Jelena / Markic, Josko

    Journal of clinical medicine

    2019  Volume 8, Issue 11

    Abstract: Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated thrombocytopenia defined as platelet count in peripheral blood <100 × ... ...

    Abstract Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated thrombocytopenia defined as platelet count in peripheral blood <100 × 10
    Language English
    Publishing date 2019-11-03
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm8111861
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Serum vitamin D levels in children with newly diagnosed and chronic immune thrombocytopenia.

    Čulić, Srđana / Markić, Joško / Petrović, Davor / Konjevoda, Paško / Pavelić, Jasminka

    Seminars in hematology

    2016  Volume 53 Suppl 1, Page(s) S67–9

    Abstract: The primary objective of the study was to assess the vitamin D (VD) status of patients suffering from ITP. Children from the case cohort (total 21) were recruited from chronic ITP patients (followed as outpatients) and newly diagnosed ITP (prospective ... ...

    Abstract The primary objective of the study was to assess the vitamin D (VD) status of patients suffering from ITP. Children from the case cohort (total 21) were recruited from chronic ITP patients (followed as outpatients) and newly diagnosed ITP (prospective study) patients. VD deficiency (values <75 nmol/L) was detected in 11 patients with newly diagnosed ITP, and seven patients with chronic ITP. Only three patients with newly diagnosed, and none with chronic ITP had normal VD values. Newly diagnosed ITP patients had statistically significantly higher values (P <.044) of VD than the patients with chronic type of ITP. Platelets values did not follow VD level. VD deficiency is very common in children with either newly diagnosed or chronic ITP form. Therefore there is a utility supplementing VD in these patients. To investigate the role of VD as an immune modulating drug for patients with ITP, a prospective randomized placebo-controlled trial needs to be performed.
    MeSH term(s) Adolescent ; Child ; Child, Preschool ; Chronic Disease ; Cohort Studies ; Female ; Humans ; Male ; Purpura, Thrombocytopenic, Idiopathic/blood ; Purpura, Thrombocytopenic, Idiopathic/immunology ; Vitamin D/blood
    Chemical Substances Vitamin D (1406-16-2)
    Language English
    Publishing date 2016-04-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 206923-4
    ISSN 1532-8686 ; 0037-1963
    ISSN (online) 1532-8686
    ISSN 0037-1963
    DOI 10.1053/j.seminhematol.2016.04.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura.

    Culić, Srdana

    British journal of haematology

    1999  Volume 120, Issue 5, Page(s) 909–910

    MeSH term(s) Child ; Chronic Disease ; Epistaxis/prevention & control ; Factor VII/therapeutic use ; Factor VIIa ; Female ; Hemostatics/therapeutic use ; Humans ; Purpura, Thrombocytopenic, Idiopathic/complications ; Recombinant Proteins/therapeutic use
    Chemical Substances Hemostatics ; Recombinant Proteins ; Factor VII (9001-25-6) ; recombinant FVIIa (AC71R787OV) ; Factor VIIa (EC 3.4.21.21)
    Language English
    Publishing date 1999-08-11
    Publishing country England
    Document type Case Reports ; Letter
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1046/j.1365-2141.2003.04151_2.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Relationship between previous maternal transfusions and haemolytic disease of the foetus and newborn mediated by non-RhD antibodies.

    Dajak, Slavica / Culić, Srđana / Stefanović, Vedran / Lukačević, Jelena

    Blood transfusion = Trasfusione del sangue

    2013  Volume 11, Issue 4, Page(s) 528–532

    Abstract: Background: The aim of this study was to determine the relationship between non-RhD immunisation and the consequent development of haemolytic disease of the newborn in pregnant women with a history of red blood cell transfusion compared to those without ...

    Abstract Background: The aim of this study was to determine the relationship between non-RhD immunisation and the consequent development of haemolytic disease of the newborn in pregnant women with a history of red blood cell transfusion compared to those without a history of transfusion.
    Materials and methods: This retrospective cohort study included all pregnancies with red blood cell antibodies that were tested between 1993 and 2010. Data were obtained from the forms for immunisation tracking at the Department of Transfusion Medicine. Each form contained data on previous maternal transfusions, antibody specificities and whether the antibodies caused haemolytic disease of the newborn.
    Results: Clinically significant non-RhD antibodies was found in 214 of 108,000 pregnancies, of which the most frequent were anti-E (n =55), anti-K (n =54), and anti-c (n =52) antibodies. A history of red blood cell transfusion was identified in 102 (48%) of the pregnancies in which non-RhD antibodies were found (in 78% of the anti-K cases, 40% of the anti-c and 18% of the anti-E cases). Non-RhD antibodies caused haemolytic disease of the newborn in 44 cases of which 14 were very severe (2 anti-K, 8 anti-c, 3 anti-Rh17, 1 anti-E). The mother had a positive history of red blood cell transfusion in 39% of the cases of haemolytic disease of the newborn. Anti-c antibodies were involved in all cases with severe haemolytic disease of the newborn and a history of maternal red blood cell transfusion.
    Conclusion: Primary prevention by using K-negative, Rhc-, RhE-, and RhC-compatible red blood cell transfusion for women younger than 45 years may prevent up to 40% of cases of haemolytic disease of the newborn. Rhc compatibile transfusion is the most important prevention strategy against severe haemolytic disease of the newborn caused by non-RhD antibodies.
    MeSH term(s) Adult ; Age Factors ; Erythroblastosis, Fetal/blood ; Erythroblastosis, Fetal/epidemiology ; Erythroblastosis, Fetal/etiology ; Erythrocyte Transfusion/adverse effects ; Female ; Follow-Up Studies ; Humans ; Infant, Newborn ; Isoantibodies/blood ; Male ; Pregnancy ; Retrospective Studies
    Chemical Substances Isoantibodies
    Language English
    Publishing date 2013-03-05
    Publishing country Italy
    Document type Clinical Trial ; Journal Article
    ZDB-ID 2135732-8
    ISSN 2385-2070 ; 0041-1787 ; 1723-2007
    ISSN (online) 2385-2070
    ISSN 0041-1787 ; 1723-2007
    DOI 10.2450/2013.0193-12
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Thrombocytopenia after bacille Calmette-Guerin immunization--possibly on an immune basis.

    Jakovljević, Gordana / Culić, Srdana

    Pediatric hematology and oncology

    2007  Volume 24, Issue 7, Page(s) 559–562

    MeSH term(s) Antigens, Bacterial/immunology ; Autoantibodies/blood ; Autoantibodies/immunology ; BCG Vaccine/adverse effects ; BCG Vaccine/immunology ; Blood Transfusion ; Combined Modality Therapy ; Cross Reactions ; Factor VII/therapeutic use ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Infant, Newborn ; Male ; Methylprednisolone/therapeutic use ; Purpura, Thrombocytopenic, Idiopathic/drug therapy ; Purpura, Thrombocytopenic, Idiopathic/etiology ; Purpura, Thrombocytopenic, Idiopathic/immunology
    Chemical Substances Antigens, Bacterial ; Autoantibodies ; BCG Vaccine ; Immunoglobulins, Intravenous ; Factor VII (9001-25-6) ; Methylprednisolone (X4W7ZR7023)
    Language English
    Publishing date 2007-10
    Publishing country England
    Document type Case Reports ; Letter
    ZDB-ID 632914-7
    ISSN 1521-0669 ; 0888-0018
    ISSN (online) 1521-0669
    ISSN 0888-0018
    DOI 10.1080/08880010701533652
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Immune thrombocytopenia: serum cytokine levels in children and adults.

    Culić, Srđana / Salamunić, Ilza / Konjevoda, Paško / Dajak, Slavica / Pavelić, Jasminka

    Medical science monitor : international medical journal of experimental and clinical research

    2013  Volume 19, Page(s) 797–801

    Abstract: Background: Immune thrombocytopenia (ITP) is an immune-mediated platelet disorder in which autoantibody-coated platelets are removed from the blood by monocytic phagocytes and there is impaired platelet production. There is a delicate balance of ... ...

    Abstract Background: Immune thrombocytopenia (ITP) is an immune-mediated platelet disorder in which autoantibody-coated platelets are removed from the blood by monocytic phagocytes and there is impaired platelet production. There is a delicate balance of specific cytokine levels, which has an important role in the immune system and is known to be deregulated in autoimmune diseases. This study was designed to investigate the differences in Th cytokine levels between children and adults with newly diagnosed ITP and to compare these profiles to those found in healthy, age-matched controls.
    Material/methods: The concentration of IL-1alpha, IL-2, IL-3, IL-4, IL-6, IL-10, TNF-alpha, IFN-alpha, and IFN-alpha in serum specimens was analyzed by enzyme-linked immunosorbent assay.
    Results: At the time of ITP diagnosis, children showed significantly lower serum levels of interleukin IL-2 and tumor necrosis factor TNF-alpha and higher serum level of IL-3 than healthy controls. Serum level of IL-4 in adult ITP patients was higher than those in control subjects. When compared with adults, children with ITP had lower serum level of IL-4, IL-6 and IFN-alpha, and higher level of IFN-alpha.
    Conclusions: Significant differences in serum cytokine levels between pediatric patients and healthy controls indicate that cytokine disturbances--especially changes in IL-2, IL-3 and TNF-alpha--might be involved in the pathogenesis of newly diagnosed ITP. TNF-alpha is the most informative variable for discrimination between healthy children and those with ITP.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Croatia ; Cytokines/blood ; Enzyme-Linked Immunosorbent Assay ; Humans ; Infant ; Interferons/blood ; Interleukins/blood ; Middle Aged ; Multivariate Analysis ; Platelet Count ; Purpura, Thrombocytopenic, Idiopathic/blood ; Tumor Necrosis Factor-alpha/blood
    Chemical Substances Cytokines ; Interleukins ; Tumor Necrosis Factor-alpha ; Interferons (9008-11-1)
    Language English
    Publishing date 2013-09-27
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1439041-3
    ISSN 1643-3750 ; 1234-1010
    ISSN (online) 1643-3750
    ISSN 1234-1010
    DOI 10.12659/MSM.884017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Relationship between tumor vascularity and vascular endothelial growth factor as prognostic factors for patients with neuroblastoma.

    Jakovljević, Gordana / Culić, Srdana / Stepan, Jasminka / Kosuta, Iva / Seiwerth, Sven

    Collegium antropologicum

    2011  Volume 35, Issue 4, Page(s) 1071–1079

    Abstract: Although the role of angiogenesis in tumor progression and response to treatment is generally well-characterized, for neuroblastomas clinical data regarding the contribution of angiogenesis and its predictive capacity remain unclear. The aim of this ... ...

    Abstract Although the role of angiogenesis in tumor progression and response to treatment is generally well-characterized, for neuroblastomas clinical data regarding the contribution of angiogenesis and its predictive capacity remain unclear. The aim of this study was to evaluate whether tumor vascularity in the combination with expression of vascular endothelial growth factor (VEGF) represent prognostic factors for patients with neuroblastoma. Immunohistochemistry using anti-CD34 and anti-VEGF antibodies was used to analyze paraffin-embedded primary tumor tissues from 56 patients diagnosed with neuroblastoma. Tumor vascularity was estimated by calculating the tumor vascular volume fraction (TVVF), and VEGF expression was determined using semi-quantitative scoring. Statistical analyses including multivariate analysis were performed and compared with these two factors. Tumor vascularity had impact on survival of high VEGF expression neuroblastoma patients. Combination of high VEGF expression and TVVF value < or = 5% was independent predictor of overall survival (p-value = 0.0041, odds ratio (OR) (95% CI) = 8.67 (1.99-37.69) by the Cox proportional hazards model). This study revealed for the first time a group of extremely high-risk neuroblastoma with both high VEGF expression and poor vascularity. For these patients reduced rates of survival were observed (37% vs. 92.5%) (p < 0.0001). These patients did not experience a significant improvement following hematopoietic stem cell transplantation, and could be candidates for receiving novel therapies. These results indicate the importance of the mutual relationship between tumor vascularity and VEGF, because it gives better insight into the prognosis of patients with neuroblastoma.
    MeSH term(s) Antigens, CD34/analysis ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Neovascularization, Pathologic ; Neuroblastoma/blood supply ; Neuroblastoma/mortality ; Prognosis ; Survival Rate ; Vascular Endothelial Growth Factor A/analysis
    Chemical Substances Antigens, CD34 ; Vascular Endothelial Growth Factor A
    Language English
    Publishing date 2011-12
    Publishing country Croatia
    Document type Journal Article
    ZDB-ID 233430-6
    ISSN 0350-6134 ; 0353-3735
    ISSN 0350-6134 ; 0353-3735
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Vascular endothelial growth factor in children with neuroblastoma

    Bonevski Aleksandra / Stepan Jasminka / Čulić Srđana / Jakovljević Gordana / Seiwerth Sven

    Journal of Experimental & Clinical Cancer Research, Vol 28, Iss 1, p

    a retrospective analysis

    2009  Volume 143

    Abstract: Abstract Background Despite aggressive therapy, advanced stage neuroblastoma patients have poor survival rates. Although angiogenesis correlates with advanced tumour stage and plays an important role in determining the tumour response to treatment in ... ...

    Abstract Abstract Background Despite aggressive therapy, advanced stage neuroblastoma patients have poor survival rates. Although angiogenesis correlates with advanced tumour stage and plays an important role in determining the tumour response to treatment in general, clinical data are still insufficient, and more clinical evaluations are needed to draw conclusions. The aim of this study was to evaluate vascular endothelial growth factor (VEGF) expression in patients with neuroblastoma, determine whether it correlates with other prognostic factors and/or therapeutic response, and to assess should VEGF be considered in a routine diagnostic workup. Materials and methods VEGF expression was determined by immunohistochemistry using anti-VEGF antibody in paraffin embedded primary tumour tissue from 56 neuroblastoma patients. Semiquantitative expression of VEGF was estimated and compared with gender, age, histology, disease stage, therapy, and survival. Statistical analyses, including multivariate analysis, were performed. Results VEGF expression correlated with disease stage and survival in neuroblastoma patients. Combination of VEGF expression and disease stage as a single prognostic value for survival (P-value = 0.0034; odds ratio (OR) (95%CI) = 26.17 (2.97-230.27) exhibited greater correlation with survival than individually. Hematopoietic stem cell transplantation significantly improved survival of the advanced stage patients with high VEGF expression. Conclusion VEGF expression should be considered in a routine diagnostic workup of children with neuroblastoma, especially in those more than 18 months old and with advanced disease stage. High VEGF expression at the time of disease diagnosis is a bad risk prognostic factor, and can be used to characterize subsets of patients with an unfavourable outcome.
    Keywords Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Oncology ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Subject code 616 ; 610
    Language English
    Publishing date 2009-11-01T00:00:00Z
    Publisher BioMed Central
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.

    Culić, Srdana / Kuljis, Dubravka / Armanda, Visnja / Jankovic, Stipan

    Pediatric blood & cancer

    2007  Volume 49, Issue 3, Page(s) 332–335

    Abstract: We present the case of an 18-year-old female with Burkitt lymphoma involving the intra-abdominal and inguinal lymph nodes. The tumor had invaded the left femoral and common iliac veins causing secondary thrombosis and vessel occlusion. Chemotherapy and ... ...

    Abstract We present the case of an 18-year-old female with Burkitt lymphoma involving the intra-abdominal and inguinal lymph nodes. The tumor had invaded the left femoral and common iliac veins causing secondary thrombosis and vessel occlusion. Chemotherapy and anticoagulant treatment resulted in mild thrombocytopenia and a prolonged prothrombin time, respectively, which exacerbated postoperative bleeding following surgical removal of a deep inguinal necrosis. After 6 days, bleeding combined with epistaxis was considered to be life threatening and anticoagulant reversal with recombinant factor VIIa was successfully performed. The patient has since achieved complete remission and subsequent antithrombotic therapy has resolved the vascular occlusion.
    MeSH term(s) Adolescent ; Anticoagulants/adverse effects ; Antineoplastic Agents/adverse effects ; Burkitt Lymphoma/complications ; Burkitt Lymphoma/drug therapy ; Factor VIIa/therapeutic use ; Female ; Femoral Vein ; Heparin, Low-Molecular-Weight/adverse effects ; Humans ; Iliac Vein ; Postoperative Hemorrhage/drug therapy ; Postoperative Hemorrhage/etiology ; Recombinant Proteins/therapeutic use ; Thrombocytopenia/chemically induced ; Thrombocytopenia/complications ; Venous Thrombosis/drug therapy ; Venous Thrombosis/etiology ; Venous Thrombosis/surgery
    Chemical Substances Anticoagulants ; Antineoplastic Agents ; Heparin, Low-Molecular-Weight ; Recombinant Proteins ; Factor VIIa (EC 3.4.21.21)
    Language English
    Publishing date 2007-09
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.20808
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Rare localization of extrarenal nephroblastoma in 1-month-old female infant.

    Armanda, Višnja / Culić, Srđana / Pogorelić, Zenon / Kuljiš, Dubravka / Budimir, Dražen / Kuzmić-Prusac, Ivana

    Journal of pediatric urology

    2012  Volume 8, Issue 4, Page(s) e43–5

    Abstract: Extrarenal occurrence of Wilms' tumor is exceptional and the diagnosis is almost always made after surgery. The exact mechanism whereby a Wilms' tumor occurs in extrarenal tissue is unknown. The tumor is most commonly located in the retroperitoneum or ... ...

    Abstract Extrarenal occurrence of Wilms' tumor is exceptional and the diagnosis is almost always made after surgery. The exact mechanism whereby a Wilms' tumor occurs in extrarenal tissue is unknown. The tumor is most commonly located in the retroperitoneum or inguinal region. Localization in subcutaneous tissue is extremely rare. In this paper, the case of a 1-month-old female infant with an extrarenal Wilms' tumor located in the lumbosacral region is presented. Surgical excision is the treatment of choice, and the same general therapeutic rules should be followed as when the kidney is affected.
    MeSH term(s) Biopsy, Needle ; Female ; Follow-Up Studies ; Humans ; Immunohistochemistry ; Infant, Newborn ; Lumbosacral Region/diagnostic imaging ; Multidetector Computed Tomography/methods ; Rare Diseases ; Retroperitoneal Neoplasms/diagnostic imaging ; Retroperitoneal Neoplasms/pathology ; Retroperitoneal Neoplasms/surgery ; Risk Assessment ; Treatment Outcome ; Wilms Tumor/diagnostic imaging ; Wilms Tumor/pathology ; Wilms Tumor/surgery
    Language English
    Publishing date 2012-08
    Publishing country England
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 2237683-5
    ISSN 1873-4898 ; 1477-5131
    ISSN (online) 1873-4898
    ISSN 1477-5131
    DOI 10.1016/j.jpurol.2012.03.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top